Latest Breaking News On - Bio science group limited - Page 1 : comparemela.com

UNI-BIO SCIENCE GROUP LIMITED: Uni-Bio Science Group Announces 2023 Annual Results

UNI-BIO SCIENCE GROUP LIMITED: Uni-Bio Science Group Announces 2023 Annual Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis riedlKingsley leungBio science group limitedNational population censusBio science group limited uniBio science groupTechnology rd centerFinancial pressSynthetic biology technology platformHydrogel technology platformChina national medical products administrationNet profitMedical aestheticsOphthalmology marketsInnovative medicineDiquafosol sodium

UNI-BIO SCIENCE GROUP LIMITED: Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)

UNI-BIO SCIENCE GROUP LIMITED: Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterFinancial pressBio science groupChina national medical products administrationBio science group limited uniDiquafosol sodiumBio science group limitedBio scienceMain boardHong kong stock exchangeFinancial press releaseDie performance strategieAssets sie

Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)

HONG KONG SAR - EQS Newswire - 23 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio Science", "the Group", stock code: 0690.HK), a fully integrated biopharmaceutical company, is pleased to announce the acceptance of its marketing application for Diquafosol Sodium eye drops by the China National Medical Products Administration ("NMPA") on 23 January 2024, with the acceptance number "CYHS2400318". This.

China national medical products administrationBio science groupBio science group limited uniBio science group limitedDiquafosol sodiumBio scienceMain boardHong kong stock exchange

Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)

<p>HONG KONG SAR - EQS Newswire - 23 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio Science", "the Group", stock code: 0690.HK), a fully integrated biopharmaceutical company, is pleased to announce the acceptance of its marketing application for Diquafosol Sodium eye drops by the China National Medical Products Administration ("NMPA") on 23 January 2024, with the acceptance number "CYHS2400318".</p>

China national medical products administrationBio science groupBio science group limited uniBio science group limitedDiquafosol sodiumBio scienceMain boardHong kong stock exchangeOriginal link

As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has

EQS Newswire / 22/01/2024 / 09:00 UTC+8As A Breakthrough Drug For The Expansive Osteoporosis Market,Bogutai® (Teriparatide Injection) Has Been Officially Approved By The ChinaNational Medical Products Administration (NMPA) Hong Kong, 22 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio", the "Company", tog.

Hong kongKingsley leungFinancial pressNational medical products administrationBio science groupChina national medical products administrationBio science group limited uniTeriparatide injectionHas been officially approved by theMedical products administrationBio science group limitedOsteoporosis diagnosisTreatment guidelineMain boardHong kong stock exchangeFinancial press release